Affordable Growth. Analyze the stocks which are showing good growth, decent profitability and health and are not overvalued from a fundamental perspective.


INCYTE CORP

Nasdaq / Health Care / Biotechnology

Fundamental Rating

7

Taking everything into account, INCY scores 7 out of 10 in our fundamental rating. INCY was compared to 588 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making INCY a very profitable company, without any liquidiy or solvency issues. INCY is evaluated to be cheap and growing strongly. This does not happen too often! These ratings could make INCY a good candidate for value and growth and quality investing.



8

1. Profitability

1.1 Basic Checks

In the past year INCY was profitable.
INCY had a positive operating cash flow in the past year.
INCY had positive earnings in 4 of the past 5 years.
Of the past 5 years INCY 4 years had a positive operating cash flow.

1.2 Ratios

INCY has a better Return On Assets (8.81%) than 96.93% of its industry peers.
INCY's Return On Equity of 11.51% is amongst the best of the industry. INCY outperforms 96.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.00%, INCY belongs to the top of the industry, outperforming 96.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INCY is below the industry average of 13.86%.
Industry RankSector Rank
ROA 8.81%
ROE 11.51%
ROIC 8%
ROA(3y)11.29%
ROA(5y)7.72%
ROE(3y)14.82%
ROE(5y)10.07%
ROIC(3y)9.11%
ROIC(5y)N/A

1.3 Margins

INCY's Profit Margin of 16.17% is amongst the best of the industry. INCY outperforms 97.27% of its industry peers.
In the last couple of years the Profit Margin of INCY has grown nicely.
Looking at the Operating Margin, with a value of 17.64%, INCY belongs to the top of the industry, outperforming 96.93% of the companies in the same industry.
In the last couple of years the Operating Margin of INCY has grown nicely.
The Gross Margin of INCY (93.71%) is better than 95.22% of its industry peers.
INCY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.64%
PM (TTM) 16.17%
GM 93.71%
OM growth 3YN/A
OM growth 5Y16.39%
PM growth 3YN/A
PM growth 5Y22.68%
GM growth 3Y-0.76%
GM growth 5Y-0.51%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INCY is destroying value.
The number of shares outstanding for INCY has been increased compared to 1 year ago.
The number of shares outstanding for INCY has been increased compared to 5 years ago.
INCY has a better debt/assets ratio than last year.

2.2 Solvency

INCY has an Altman-Z score of 5.99. This indicates that INCY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.99, INCY belongs to the best of the industry, outperforming 81.57% of the companies in the same industry.
INCY has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
INCY has a better Debt to FCF ratio (0.07) than 97.61% of its industry peers.
INCY has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.01, INCY perfoms like the industry average, outperforming 47.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.07
Altman-Z 5.99
ROIC/WACC0.87
WACC9.2%

2.3 Liquidity

A Current Ratio of 3.75 indicates that INCY has no problem at all paying its short term obligations.
INCY has a Current ratio (3.75) which is comparable to the rest of the industry.
INCY has a Quick Ratio of 3.69. This indicates that INCY is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 3.69, INCY perfoms like the industry average, outperforming 42.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.75
Quick Ratio 3.69

7

3. Growth

3.1 Past

INCY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.62%, which is quite impressive.
Measured over the past years, INCY shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.86% on average per year.
Looking at the last year, INCY shows a quite strong growth in Revenue. The Revenue has grown by 8.87% in the last year.
INCY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.45% yearly.
EPS 1Y (TTM)26.62%
EPS 3YN/A
EPS 5Y27.86%
EPS growth Q2Q70.97%
Revenue 1Y (TTM)8.87%
Revenue growth 3Y11.49%
Revenue growth 5Y14.45%
Revenue growth Q2Q9.35%

3.2 Future

Based on estimates for the next years, INCY will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.66% on average per year.
The Revenue is expected to grow by 8.13% on average over the next years. This is quite good.
EPS Next Y31.69%
EPS Next 2Y24.97%
EPS Next 3Y24.94%
EPS Next 5Y18.67%
Revenue Next Year12.46%
Revenue Next 2Y11.59%
Revenue Next 3Y11.38%
Revenue Next 5Y8.13%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.27, INCY is valued correctly.
Based on the Price/Earnings ratio, INCY is valued cheaper than 97.10% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.28. INCY is valued slightly cheaper when compared to this.
INCY is valuated reasonably with a Price/Forward Earnings ratio of 11.60.
INCY's Price/Forward Earnings ratio is rather cheap when compared to the industry. INCY is cheaper than 98.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, INCY is valued a bit cheaper.
Industry RankSector Rank
PE 15.27
Fwd PE 11.6

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INCY indicates a rather cheap valuation: INCY is cheaper than 97.95% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INCY indicates a rather cheap valuation: INCY is cheaper than 96.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.01
EV/EBITDA 10.09

4.3 Compensation for Growth

INCY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of INCY may justify a higher PE ratio.
A more expensive valuation may be justified as INCY's earnings are expected to grow with 24.94% in the coming years.
PEG (NY)0.48
PEG (5Y)0.55
EPS Next 2Y24.97%
EPS Next 3Y24.94%

0

5. Dividend

5.1 Amount

INCY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A